# A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck

> **NCT07644585** · NA · RECRUITING · sponsor: **IBA Proton Therapy, Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **RADIATION:** ConformalFLASH irradiation

## Key facts

- **NCT ID:** NCT07644585
- **Lead sponsor:** IBA Proton Therapy, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-14
- **Primary completion:** 2027-12
- **Final completion:** 2032-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07644585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07644585, "A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07644585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
